Back to results
US 2003/0158237 A1Published application
Combination of antioxidant substances for the treatment of alzheimer's disease
AssigneeColba R & D Inc.
InventorsUri Saragovi, Joseph Bassili, Khassam Elfarrah
Life of this patent
Estimating the term…
Abstract
Disclosed is a pharmaceutical composition for the treatment of cognitive symptoms caused by Alzheimer's disease in a mammal. This composition comprising vitamin E, quercitin, caffeic acid, nicotinic acid or derivatives and/or analog thereof, and a pharmaceutically acceptable excipient.
Claims20
A pharmaceutical composition for the treatment of cognitive symptoms caused by Alzheimer's disease in a mammal, wherein said composition comprises vitamin E, quercitin, caffeic acid, nicotinic acid or derivatives and/or analogs thereof, and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.